Related Suggestion
(Dongguan, China, March 30, 2021) During
September 28-30, Fapon Biotech has attended 2021 AACC Annual Scientific Meeting
& Clinical Lab Expo (2021 AACC), which is held in Atlanta, GA, USA. While the
2021 AACC will showcase the cutting-edge science and technology shaping the
future of laboratory medicine, Fapon Biotech is pleased to bring about its optimized
core reagent raw materials as well as newly developed open instruments
platforms with our business partners at the exhibition booth of 2754.
Although the haze of COVID-19 epidemic is
still lingering, people remain determined to overcome this battle with the
virus. With the continuous improvement of vaccination coverage rate and
effective hygiene and safety measures on site, 2021 AACC was held as scheduled at
the Georgia World Congress Center in Atlanta. The visitors and exhibitors were
organized in an orderly manner, discussing the trend of medical development and
sharing the latest scientific advances.
Attendees showed great interests in Fapon’s
core reagent raw materials, especially COVID-19 related products. As a provider
of excellent raw materials and customized IVD solutions, Fapon Biotech acts
promptly to fight against the virus by constantly provide One-Stop SARS-CoV-2
Testing Solutions to the downstream diagnostic companies. Thousands of grams of
antibodies and antigens developed from Fapon Biotech have been provided to
global customers whose reagents received approvals from government bodies like
FDA, NMPA, ICMR, Anvisa, etc. In addition, our star raw material products of
cardiac marker and tumor marker are also popular among American customers,
featured parameters including NT-proBNP, MYO, CA153, CA125 and so on.
The demonstration of our two open
instrument platforms, Shine i1000 CLIA fully automatic analyzer (120T/H) and P810
real-time PCR analyzer, has gained great attention from the booth visitors.
Numerous appointed customers visit to discover new ways to achieve measurably
better clinical performance and even indicated a potential purchase intention.
In addition, onsite guests, visitors and
media were also impressed by the new brand identity revealed by Fapon Biotech.
The company was pleased to show its initial offline launch of the new brand
properties to the international market through AACC Expo. This refreshed brand
image was created to better reflect on the corporate focus of which enabling
Disease Identification Earlier, More Accurate, Convenient and Affordable is the
ultimate mission of the company.
Congratulation on Fapon Biotech‘s another showcase return at 2021 AACC. Deep gratitude to all guests who visited and expressed their supports to us.
